Embracing the dawn of 2024, New Day Diagnostics is at the forefront of a healthcare revolution. Following a strategic merger and a game-changing asset purchase agreement, the Knoxville-based powerhouse, led by CEO Eric Mayer, is set to redefine diagnostics, focusing on expanding its portfolio to include over-the-counter solutions for various ailments. With a $15 million funding round underway, a commitment … Read More